IRVING, Texas, April 22, 2026--biote Corp. (Nasdaq: BTMD) ("Biote" or the "Company"), a leader in innovative hormone optimization and healthy aging solutions that advance the healthspan of our ...

It is usually uneventful when a single insider buys stock. However, When quite a few insiders buy shares, as it happened in biote Corp.'s (NASDAQ:BTMD) case, it's fantastic news for shareholders.

Management rebuilt the commercial organization in 2025, grew the salesforce to just over 90 and plans to expand to approximately 120 in 2026 while investing in technology—moves management says are ...

biote Corp. returned to profitability in Q3 2023 and is expected to continue to be profitable in the future. The company's growth is driven by the sale of hormone replacement therapy products and its ...

We recently published a list of 10 Micro-Cap Stocks Insiders Were Buying In Q1 2025. In this article, we are going to take a look at where biote Corp. (NASDAQ:BTMD) stands against other micro-cap ...

IRVING, Texas, March 18, 2025--biote Corp. (NASDAQ: BTMD) ("Biote" or the "Company") a leading solutions provider in preventive health care through the delivery of personalized hormone optimization ...

biote Corp. (BTMD) came out with quarterly earnings of $0.06 per share, beating the Zacks Consensus Estimate of $0.05 per share. This compares to earnings of $0.1 per share a year ago. These figures ...

The recall involves the following brands: Arey, Bari Life, Bird&Be, Biote, Dr Fuhrman, NuLife, HMR, Bariatric Pal, Noevir, ...

IRVING, Texas--(BUSINESS WIRE)-- BioTE Holdings, LLC, (Biote), a high-growth, differentiated medical practice-building business within the hormone optimization space ...

The founder of an Irving-based hormone optimization company is on a mission to take it back, saying executives he hired to protect it ended up hijacking it and diluting his ownership by nearly $220 ...